162 related articles for article (PubMed ID: 11277075)
1. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways.
Morriss-Kay GM; Iseki S; Johnson D
Novartis Found Symp; 2001; 232():102-16; discussion 116-21. PubMed ID: 11277075
[TBL] [Abstract][Full Text] [Related]
2. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault.
Iseki S; Wilkie AO; Morriss-Kay GM
Development; 1999 Dec; 126(24):5611-20. PubMed ID: 10572038
[TBL] [Abstract][Full Text] [Related]
3. Fgfr2 and osteopontin domains in the developing skull vault are mutually exclusive and can be altered by locally applied FGF2.
Iseki S; Wilkie AO; Heath JK; Ishimaru T; Eto K; Morriss-Kay GM
Development; 1997 Sep; 124(17):3375-84. PubMed ID: 9310332
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of Twist and Fgfr1, -2 and -3 in the developing mouse coronal suture suggest a key role for twist in suture initiation and biogenesis.
Johnson D; Iseki S; Wilkie AO; Morriss-Kay GM
Mech Dev; 2000 Mar; 91(1-2):341-5. PubMed ID: 10704861
[TBL] [Abstract][Full Text] [Related]
5. Integration of FGF and TWIST in calvarial bone and suture development.
Rice DP; Aberg T; Chan Y; Tang Z; Kettunen PJ; Pakarinen L; Maxson RE; Thesleff I
Development; 2000 May; 127(9):1845-55. PubMed ID: 10751173
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanisms in calvarial bone and suture development, and their relation to craniosynostosis.
Rice DP; Rice R; Thesleff I
Eur J Orthod; 2003 Apr; 25(2):139-48. PubMed ID: 12737212
[TBL] [Abstract][Full Text] [Related]
7. Fibroblast growth factors lead to increased Msx2 expression and fusion in calvarial sutures.
Ignelzi MA; Wang W; Young AT
J Bone Miner Res; 2003 Apr; 18(4):751-9. PubMed ID: 12674336
[TBL] [Abstract][Full Text] [Related]
8. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts.
Mansukhani A; Bellosta P; Sahni M; Basilico C
J Cell Biol; 2000 Jun; 149(6):1297-308. PubMed ID: 10851026
[TBL] [Abstract][Full Text] [Related]
9. Craniosynostosis: genes and mechanisms.
Wilkie AO
Hum Mol Genet; 1997; 6(10):1647-56. PubMed ID: 9300656
[TBL] [Abstract][Full Text] [Related]
10. Toward an understanding of nonsyndromic craniosynostosis: altered patterns of TGF-beta receptor and FGF receptor expression induced by intrauterine head constraint.
Hunenko O; Karmacharya J; Ong G; Kirschner RE
Ann Plast Surg; 2001 May; 46(5):546-53; discussion 553-4. PubMed ID: 11352430
[TBL] [Abstract][Full Text] [Related]
11. Induction of chondrogenesis in neural crest cells by mutant fibroblast growth factor receptors.
Petiot A; Ferretti P; Copp AJ; Chan CT
Dev Dyn; 2002 Jun; 224(2):210-21. PubMed ID: 12112473
[TBL] [Abstract][Full Text] [Related]
12. The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation.
Lemonnier J; Delannoy P; Hott M; Lomri A; Modrowski D; Marie PJ
Exp Cell Res; 2000 Apr; 256(1):158-67. PubMed ID: 10739663
[TBL] [Abstract][Full Text] [Related]
13. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive screen of genes implicated in craniosynostosis.
Johnson D
Ann R Coll Surg Engl; 2003 Nov; 85(6):371-7. PubMed ID: 14629875
[TBL] [Abstract][Full Text] [Related]
15. Description of a new mutation and characterization of FGFR1, FGFR2, and FGFR3 mutations among Brazilian patients with syndromic craniosynostoses.
Passos-Bueno MR; Sertié AL; Richieri-Costa A; Alonso LG; Zatz M; Alonso N; Brunoni D; Ribeiro SF
Am J Med Genet; 1998 Jul; 78(3):237-41. PubMed ID: 9677057
[TBL] [Abstract][Full Text] [Related]
16. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development.
Kim HJ; Rice DP; Kettunen PJ; Thesleff I
Development; 1998 Apr; 125(7):1241-51. PubMed ID: 9477322
[TBL] [Abstract][Full Text] [Related]
17. Activating (P253R, C278F) and dominant negative mutations of FGFR2: differential effects on calvarial bone cell proliferation, differentiation, and mineralization.
Ratisoontorn C; Fan GF; McEntee K; Nah HD
Connect Tissue Res; 2003; 44 Suppl 1():292-7. PubMed ID: 12952211
[TBL] [Abstract][Full Text] [Related]
18. Craniosynostosis and related limb anomalies.
Wilkie AO; Oldridge M; Tang Z; Maxson RE
Novartis Found Symp; 2001; 232():122-33; discussion 133-43. PubMed ID: 11277076
[TBL] [Abstract][Full Text] [Related]
19. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
20. Negative autoregulation of fibroblast growth factor receptor 2 expression characterizing cranial development in cases of Apert (P253R mutation) and Pfeiffer (C278F mutation) syndromes and suggesting a basis for differences in their cranial phenotypes.
Britto JA; Moore RL; Evans RD; Hayward RD; Jones BM
J Neurosurg; 2001 Oct; 95(4):660-73. PubMed ID: 11596961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
